𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab

✍ Scribed by Kathrin Wanner; Susanne Hipp; Madlene Oelsner; Ingo Ringshausen; Christian Bogner; Christian Peschel; Thomas Decker


Book ID
108673876
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
818 KB
Volume
134
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibition of mammalian target of rapamy
✍ Nadine Darwiche; Ansam Sinjab; Ghada Abou-Lteif; Mirella Bou Chedid; Olivier Her πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 731 KB

## Abstract HTLV‐I‐associated adult T‐cell leukemia/lymphoma (ATL) and human T‐cell lymphotropic virus type I (HTLV‐I)‐negative peripheral T‐cell lymphomas carry poor prognosis mainly because of acquired resistance to chemotherapy. We have shown that this disease is responsive to the combination of

Inhibition of mammalian target of rapamy
✍ Chie Nishioka; Takayuki Ikezoe; Jing Yang; Sigal Gery; H. Phillip Koeffler; Akih πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 828 KB

## Abstract Our study explored the drug interaction of all‐__tran__s retinoic acid (ATRA) and RAD001 (everolimus), the inhibitor of mammalian target of rapamycin complex 1 (mTORC1), in acute myelogenous leukemia (AML) NB4 and HL60 cells. RAD001 (10 nM) significantly enhanced the ATRA‐induced growth